These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5551196)

  • 1. Metabolic fate of amphetamine in the cat during development of tolerance.
    Ellison T; Okun R; Silverman A; Siegel M
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):135-49. PubMed ID: 5551196
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Studies on the uptake of D-amphetamine by rat cerebral cortex slices.
    Magour S; Coper H; Fähndrich C
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R62. PubMed ID: 4276611
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative potencies of d- and l-amphetamine on the release of dopamine from cat brain in vivo.
    Chiueh CC; Moore KE
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):189-99. PubMed ID: 4811449
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative metabolism of dl-3H-amphetamine hydrochloride in tolerant and nontolerant cats.
    Ellison T; Siegel M; Silverman AG; Okun R
    Proc West Pharmacol Soc; 1968; 11():75-7. PubMed ID: 5734492
    [No Abstract]   [Full Text] [Related]  

  • 5. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
    Magour S; Coper H; Fähndrich C
    Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the metabolism and distribution of radioactive amphetamine.
    Winters RH; Levy L; Thurman W; Okun R
    Proc West Pharmacol Soc; 1966; 9():1-3. PubMed ID: 5958493
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic study of amphetamine elimination in dogs and swine.
    Baggot JD; Davis LE
    Biochem Pharmacol; 1972 Jul; 21(14):1967-76. PubMed ID: 4649345
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of the reversal of the effect of guanethidine by amphetamines in cat and man.
    Flegin OT; Morgan DH; Oates JA; Shand DG
    Br J Pharmacol; 1970 May; 39(1):253P-254P. PubMed ID: 5420141
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue distribution of dl-3H-amphetamine HC1 in tolerant and nontolerant cats.
    Siegel M; Ellison T; Silverman AG; Okun R
    Proc West Pharmacol Soc; 1968; 11():90-4. PubMed ID: 5734494
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of amphetamine tolerance and metabolism by propranolol.
    Shoeman DW; Sirtori CR; Azarnoff DL
    J Pharmacol Exp Ther; 1974 Oct; 191(1):68-71. PubMed ID: 4418151
    [No Abstract]   [Full Text] [Related]  

  • 11. The conversion in vivo of D-amphetamine to (+)-p-hydroxynorephedrine.
    Goldstein M; Anagnoste B
    Biochim Biophys Acta; 1965 Aug; 107(1):166-8. PubMed ID: 5857361
    [No Abstract]   [Full Text] [Related]  

  • 12. A determination of the anorexigenic potential of dl-amphetamine, d-amphetamine, l-amphetamine and phentermine.
    Lawlor RB; Trivedi MC; Yelnosky J
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):401-7. PubMed ID: 5367311
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of effect of amantadine on d-amphetamine-induced release of dopamine from cat brain in vivo.
    Gudelsky GA; McCall RB; Chiueh CC; Moore KE
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):653-60. PubMed ID: 4456497
    [No Abstract]   [Full Text] [Related]  

  • 15. The comparative metabolism of d-amphetamine-C14 in the rat, dog and monkey.
    Ellison T; Gutzait L; Van Loon EJ
    J Pharmacol Exp Ther; 1966 Jun; 152(3):383-7. PubMed ID: 4958760
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenylacetone oxime--an intermediate in amphetamine deamination.
    Hucker HB
    Drug Metab Dispos; 1973; 1(1):332-6. PubMed ID: 4149401
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of d- and l- amphetamine on fixed-interval and fixed-ratio behavior in tolerant and nontolerant rats.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):372-9. PubMed ID: 4748553
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of d- and l-amphentamine on hypothalamically-elicited movement and attack in the cat.
    Marini JL; Walters JK; Sheard MH
    Agressologie; 1979; 20(3):155-60. PubMed ID: 575607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.